Use of rasagiline for the treatment of Progressive Supranuclear Palsy

Details for Australian Patent Application No. 2010304755 (hide)

Owner Teva Pharmaceutical Industries, Ltd.

Inventors Lorenzl, Stefan

Agent FB Rice

Pub. Number AU-A-2010304755

PCT Pub. Number WO2011/042812

Priority 61/278,677 09.10.09 US

Filing date 8 October 2010

Wipo publication date 14 April 2011

International Classifications

A61K 31/136 (2006.01) - having the amino group directly attached to the aromatic ring, e.g. benzeneamine

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

24 May 2012 PCT application entered the National Phase

  PCT publication WO2011/042812 Priority application(s): WO2011/042812

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010304759-Treatment of folded articles

2010304754-Isoelastic porous mesh